TY  - JOUR
AU  - Fernandez-Lopez, Cristina
AU  - Calleja-Hernandez, Miguel Angel
AU  - Balbino, Jaime Espin
AU  - Cabeza-Barrera, Jose
AU  - Exposito-Hernandez, Jose
PY  - 2019
DO  - 10.1111/1759-7714.13024
UR  - http://hdl.handle.net/10668/13701
T2  - Thoracic cancer
AB  - The objective of this review was to investigate trends in clinical trial design, specifically, the primary outcomes used, interpretation of results, and the magnitude of the benefits described in phase III controlled clinical trials in the first-line...
LA  - en
PB  - John Wiley & Sons, Inc.
KW  - Non-small-cell lung cancer
KW  - outcome assessment (health care)
KW  - quality of life
KW  - retrospective study
KW  - survival analysis
KW  - Antineoplastic Agents
KW  - Carcinoma, Non-Small-Cell Lung
KW  - Clinical Trials, Phase III as Topic
KW  - Disease-Free Survival
KW  - Endpoint Determination
KW  - Female
KW  - Humans
KW  - Lung Neoplasms
KW  - Male
KW  - Quality of Life
KW  - Randomized Controlled Trials as Topic
KW  - Retrospective Studies
KW  - Sample Size
KW  - Survival Analysis
KW  - Treatment Outcome
TI  - Trends in endpoint selection and result interpretation in advanced non-small cell lung cancer clinical trials published between 2000 and 2012: A retrospective cohort study.
TY  - research article
VL  - 10
ER  -